Genelux (GNLX) Revenue (2022 - 2024)
Genelux (GNLX) posted Revenue of $8000.0 for Q1 2024, down 95.29% on a QoQ basis from $170000.0 in Q1 2023, and down 95.29% year-over-year from $170000.0 in Q2 2023.
Analysis
Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends
Genelux has reported Revenue for 3 years, with the latest figure at $8000.0 in Q1 2024.
- On a quarterly basis, Revenue fell 95.29% year-over-year to $8000.0 in Q1 2024; TTM through Dec 2024 was $8000.0, a 95.29% decrease from a year earlier, with the FY2025 full-year figure at $8000.0, changed 0.0% from the prior year.
- Revenue was $8000.0 for Q1 2024 at Genelux, down from $170000.0 in the prior quarter.
- The five-year high for Revenue was $11.0 million in Q3 2022, with the low at $8000.0 in Q1 2024.
- Average Revenue over 3 years is $2.8 million, with a median of $119000.0 recorded in 2022.
- The largest YoY upside for Revenue was 95.29% in 2024 against a maximum downside of 95.29% in 2024.
- Over 3 years, Revenue stood at $68000.0 in 2022, then surged by 150.0% to $170000.0 in 2023, then sank by 95.29% to $8000.0 in 2024.
- The last three Revenue figures came in at $8000.0 (Q1 2024), $170000.0 (Q1 2023), and $68000.0 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Dec 31, 2022 | 68,000.00 |
| Sep 30, 2022 | 11.00 Mn |